Authors


Timothy N. Troy

Latest:

Limited TIMs?

London -- A report published by Britain's National Prescribing Center saying that Fujisawa's Protopic (tacrolimus) and Novartis' Elidel (pimecrolimus) have only a limited role in the treatment of eczema was intended for general practitioners rather than dermatologists and refers mostly to mild cases treated in primary care settings.


David J. Goldberg, MD, JD

Latest:

I Used Botulinum Toxin for Migraines—Now I’ve Been Sued

David Goldberg, MD, JD, stated the use of drugs and devices for conditions that are not otherwise indicated is widespread among physicians and is generally not considered experimental or investigational.


Chet Scerra

Latest:

Same-Day Tx

San Francisco - Two new dermal fillers approved for use without a pre-treatment skin test will enable dermatologists to offer patients same-day collagen replacement therapy.


Lisette Hilton

Latest:

Experts Weigh in on Best Body-Focused Skin Care

Slathering the body with the same skin-care products designed for the face is a bad idea, experts say.


Lisette Hilton

Latest:

French Results Echo Expert Findings

According to a study in Annals of Dermatology and Venerology, pediatric patients with psoriasis in France frequently missed dermatologic consultations.


John Jesitus

Latest:

Mouse Model May Shed Light on APC mutations in brain metastases

A grant from the Melanoma Research Foundation powers the initial stages of the project.


Barbara J. Rutledge, PhD

Latest:

Skin disease in tropical travelers

National report - Skin disease is one of the main reasons for consultation in travelers returning from the tropics, according to Eric Caumes, M.D., professor of infectious diseases and dermatologist in the department of infectious and tropical diseases at Hospital Piti?-Salp?tri?re in Paris.


Lisette Hilton

Latest:

Hemangioma treatment side effects linked to low body weight

Bronchial hyperreactivity associated with propranolol treatment for infantile hemangiomas may be due to age and low body weight, study shows.


Ilya Petrou M.D

Latest:

Chemical lift with a phenol peel

The patient must be psychologically prepared for the clinical picture of the desquamation that results from the peel.


David B. Mandell, J.D., M.B.A

Latest:

Bail yourself out: Recover investment losses with tax benefits

The current financial crisis has left many Americans with less wealth than they had just a year ago. Home and stock market investments are likely worth a lot less ? and it may be years until the values of these assets return to previous levels. Investment advisers Carole C. Foos, C.P.A., and David B. Mandell, J.D., M.B.A., offer a strategy with two simple steps to help you start now to make up for your losses.


Michelle Sprehe

Latest:

Onset acquires rights to acne med Clindagel

The acne medication Clindagel (clindamycin phosphate 1 percent) topical gel is now owned by Onset Dermatologics, according to a news release.


Staff reports

Latest:

Many with psoriasis go untreated

Up to 30 percent of patients with psoriasis do not seek medical care for their skin condition, patient surveys show.


Sarah Thuerk

Latest:

FDA approves injectable foam for varicose veins

The Food and Drug Administration has approved Varithena (polidocanol injectable foam, BTG International) for the treatment of varicose veins.


Randy Dotinga

Latest:

Isotretinoin: Time to reconsider blood test best practices

While oral isotretinoin has been associated with various side effects and routine blood tests have been recommended, evidence points to inconsistencies in monitoring practices. Many physicians also are questioning whether the effort has value.


Patricia K. Farris, MD

Latest:

Science of Skincare Summit Co-Chairs Preview Cutting-Edge September Program

Patricia Farris, MD, and Ted Lain, MD, MBA, co-chairs of the Science of Skincare Summit, discuss their excitement for the September conference and its innovative educational experience.


Darin Painter

Latest:

Are you missing this business tool?

Balancing a career or business, a family and a household is a given for many of us. When it comes to keeping cool and maintaining relationships with family, colleagues and our patients, communication and education are key. Here's how one tool can help.


Sandy Johnson, M.D.

Latest:

Antibiotic dialogue needs to continue

I thoroughly enjoyed the lead article about “antimicrobial stewardship” in the October edition of Dermatology Times (“Antimicrobial stewardship: How dermatologists can be part of the solution, Vol. 34, No. 10). It succinctly and effectively detailed that for healthcare providers in general and dermatologists in specific, it is our duty to utilize antimicrobials appropriately.


Eliza Cabana

Latest:

The Aesthetic Practice in 2021

What will the aesthetic medicine look like in 2021? Dr. Suneel Chilukuri offers his perspective on how the pandemic will influence the practice in the New Year.


Bill Gillette

Latest:

Laser technology creates hi-res maps of acne lesions

An exploration of the feasibility of using laser technology to detect changes in microvasculature during the acne lesion healing progress and to introduce a microvasculature-based biomarker in evaluating the treatment and grading of acne.


Andrew D. Bowser

Latest:

Combination therapy improves survival in melanoma

The combination of encorafenib plus binimetinib significantly improved overall survival versus vemurafenib in patients with BRAF-mutant melanoma, updated results of the randomized, phase three COLUMBUS trial show.


Eliot F. Battle, Jr., M.D.

Latest:

Skin of Color Seminar Series roundup

A panel discussion on the increasing trend of total body skin lightening ― and ethical and health concerns associated with skin lightening ― was this year's most discussesd and controversial topic.


Cheryl Bisera

Latest:

Self-care Before Patient Care : 10 Ways to Boost Your Resilience in 2018 - Part 2

In April we reviewed the first five tips to help boost your resilience and well being in 2018. Below are the final five in the second part of this two-part article.


Jeff Craven

Latest:

More new therapies under study for underarm sweat

Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.


Justin Knott, president, Intrepy Healthcare Marketing

Latest:

8 Ways to improve Instagram results

Marketing expert Justin Knott explains how to grow your Instagram following as part of a successful digital practice marketing strategy.


Anna Sarno Ryan, M.D.

Latest:

The journey begins when the trip ends

WE medical trip to India ends in eye-opening lessons learned.


Andrew Frankel, Chief Operating Officer, Pennsylvania Dermatology Partners, Philadelphia

Latest:

Technology: A private practice’s best friend

Pennsylvania Dermatology Partners tells its story of technological support and success.


Galadriel Bonnel, Ph.D., FNP

Latest:

Life-threatening emergency cases in dermatology

Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.


Nia Cason

Latest:

A review of treatment for dermatofibrosarcoma

Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.


Steve Xu, MD, MSc, FAAD

Latest:

Benzene Concerns in Benzoyl Peroxide Spark Calls for Safer Acne Treatment Standards

As news of benzene contamination in benzoyl peroxide products continues to raise safety discussions, Steve Xu, MD, MSc, advocates for stricter regulations, increased research, and the consideration of safer acne treatment alternatives.


William Ju., M.D., FAAD

Latest:

Continuing the innovation journey

In recognition of the first anniversary of our Innovation column, Drs. Steve Xu and William Ju reflect on the range of topics covered throughout the year and highlight what's to come.

© 2024 MJH Life Sciences

All rights reserved.